FTC Targets California Stem Cell Clinics
“Deceptive” and “false” are two words used by the U.S. Federal Trade Commission (FTC) to describe marketing claims by two stem cell treatment clinics in California. According to an FTC complaint, the clinics had been advertising that they were using amniotic stem cell therapy to successfully treat serious diseases, including multiple sclerosis, autism, stroke, and heart attacks. The claims included one advertisement saying their treatment restored sight for a 101-year-old woman who had been…Continue Reading